Anesthetic Management with Total Intravenous Anesthesia in Hereditary Spherocytosis: A Case Report
Herediter Sferositoz’da Total İntravenöz Anestezi ile Anestezi Yönetimi
Abstract views: 462 / PDF downloads: 99
DOI:
https://doi.org/10.5152/eurjther.2017.33Keywords:
Hereditary spherocytosis, anesthesia management, TIVA, propofolAbstract
Hereditary spherocytosis (HS) is a type of hemolytic anemia. Anesthetic management of any surgery with HS requires close monitoring of hypothermia, hypoxia, acidosis, and postoperative pain. We report a case of a 14-year-old male patient with HS scheduled for laparoscopic cholecystectomy. He was operated for splenectomy 5 years prior to admission. Hemoglobin (Hb) was 11.5 g/dL, platelets were 2,97,000 /mL, and total bilirubin was 4.50 mg/dL with direct bilirubin being 0.41 mg/dl. In peripheral blood smear (PBS) before surgery, spherocytosis percentage was 19%. He was premedicated with midazolam. After induction with propofol, fentanyl, and atracurium, anesthesia was maintained with air and O2 and total intravenous anesthesia (TIVA) was maintained with propofol and remifentanil. Electrocardiography, non-invasive blood pressure, peripheral oxygen saturation, and end-tidal carbon dioxide were monitored. We used an air warmer blanket to avoid hypothermia. Intraoperative arterial blood gas (ABG) values were evaluated at pH 7.37 (PCO2 = 38.1 mm Hg, PO2 = 177 mm Hg, Hb = 11.5 g/dL, and glucose = 109 mg/dL). Furthermore, intraoperative PBS was repeated, and spherocyte percentage was 11%. In post-anesthesia care unit, ABG values at pH 7.36 for PCO2, PO2, and Hb were 37.4 mm Hg, 210 mm Hg, and 11.4 g/dL, respectively. PBS was repeated on the next day, and spherocyte percentage was 16%. Multimodal analgesia was provided with tramadol, paracetamol, and local infiltration of the surgical site. Paracetamol infusion was given postoperatively three times a day for pain control. Intraoperative spherocyte percentage was less than that observed in preoperative PBS (11% and 19%, respectively). We consider that TIVA decreased spherocytes owing to appropriate anesthetic management, ABG stabilization, and normothermia each, either alone or together. On the next day, the spherocyte percentage was increased (16%) but still remained below the first spherocyte count. We consider that this is due to good pain control and well-balanced hydration. In conclusion, TIVA provided a safe anesthetic management.
Metrics
References
Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P, King MJ; General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis-2011 update. Br J Haematol 2012; 6: 156: 37-49.
Hassan A, Babadoko AA, Isa AH, Abunimye P. Hereditary Spherocytosis in a 27-year old female: casereport. Annals of African Medicine 2009; 8: 61-3.
Nobili C, Romano F, Ciravegna AL, Garancini M, Degrate L, Uggeri F, et al. Consecutive concomitant laparoscopic splenectomy and cholecystectomy: an Italian experience of 30 patients and proposition of a technique. J Laparoendosc Adv Surg Tech 2011; 21: 313-7
Malliwal A, Mehta S, Bakhshi R, Mahapatra B. Anaesthetic considerations for patient of Hereditary Spherocytosis for splenectomy and cholecystectomy: A case report. Indian Journal of Basic and Applied Medical Research 2014; 11: 295-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.